SkyBridge Capital II’s Cardinal Health CAH Stock Holding History

SkyBridge Capital II’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-51,907	Closed	-$2.44M	–	5
2019 Q2	$2.44M	Buy	+51,907	New	+$2.39M	3.5%	13

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AIG

American International Group New York $2.93M AUM 12.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SkyBridge Capital II's CAH Position: Q3 2019 in Review

SkyBridge Capital II sold out of Cardinal Health (CAH) in Q3 2019, closing a stake of 51,907 shares — an estimated $2.44M sold.

SkyBridge Capital II first reported a position in CAH in Q2 2019 and held it in 1 quarter. The position peaked at $2.44M in Q2 2019. 664 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

SkyBridge Capital II reported no remaining Cardinal Health position as of Q3 2019 after selling out during the quarter.
SkyBridge Capital II sold 51,907 Cardinal Health shares in Q3 2019, an estimated $2.44M.
SkyBridge Capital II first reported a position in Cardinal Health in Q2 2019 and held it in 1 quarter.
SkyBridge Capital II's Cardinal Health position peaked at $2.44M in Q2 2019.
664 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on SkyBridge Capital II's 13F filing for Q3 2019.